Telitacicept Prompts Positive Responses in Lupus Treatment

Phase 2b study data also showed a dose reduction in glucocorticoids among those who received the investigational drug compared with patients who received placebo.
Medscape Medical News

source https://www.medscape.com/viewarticle/telitacicept-phase-2-trial-prompts-positive-responses-2024a10000tc?src=rss